Guest Editor
Peter Ujhazy
National Cancer Institute, Bethesda, MD, USA.
This series does not attempt to completely list all the recent progress in SCLC research that has been well covered elsewhere in recent reviews. Rather it focuses more in depth on a few critical developments that may lead to improved diagnosis and interventions for SCLC patients. The field is rapidly moving forward and we will hopefully see translation of these new discoveries into clinical practice soon.